This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Robust medical: it plans to acquire the controlling equity of Hunan Ping An medical equipment
Imber: the shareholder Ruan bin has completed the reduction of 337500 shares and plans to continue to reduce no more than 1.32% of the shares
Robust medical: by the end of October, 1159400 shares had been repurchased
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
CelcomDigi Berhad and AmBank Sign MOU to Drive Digital Healthcare Transformation
CelcomDigi Berhad today announced the signing of a three-year Memorandum of Understanding (MoU) with AmBank (M) Berhad and AmBank Islamic Berhad, with the aim of empowering healthcare providers in Malaysia through digital healthcare solutions.
Oct 29, 2024 05:36 PM
Robust medical treatment: affected by the recent spread of delta virus strain, the company's demand for protective products such as masks and protective clothing has increased significantly
China's New Energy Intelligent Vehicle Industry Chain Enterprises Have Opened a New Era
Feb 27, 2025 03:42 PM
AIEV Leads the Way into a New Era of Automotive Intelligence
Feb 27, 2025 03:27 PM
Witnessing History: The New Globalization Landscape of 2025 (Part II)
Feb 24, 2025 09:49 PM